The recent significant penalty imposed on Medtronic sends a strong warning to companies supplying therapeutic goods in Australia. It reinforces the central position of the Australian Register of ...

Medtronic plc has announced United States Food and Drug Administration (FDA) approval of the Affera Mapping and Ablation ...

This approval is expected to help in treatment of persistent AFib and for RF ablation of CTI dependent atrial flutter.

The Affera Mapping and Ablation System and Sphere-9 catheter also received CE Mark in March 2023 and was approved in Australia in September 2024. In October 2024, Medtronic announced the start of ...

IMR is currently undertaking its Vision-MR Ablation of Atrial Flutter (VISABL-AFL) pivotal clinical trial supporting US FDA ...

Lumbosacral Radicular Pain Management MarketThe global lumbosacral radicular pain management market is poised for significant ...

The Affera mapping and ablation system is the first on the market that can deliver both pulsed-field and radiofrequency ...

Boston Scientific Corporation's acquisition of Axonics, Inc. for $3.7 billion expands urology offerings with innovative ...

Toronto's premier private secondary school, formerly known as Queens Collegiate, unveils its new identity: Queens Grove School. As part of the Opulence Education Group, Queens Grove School remains ...

Assistive Technology for Elder market is projected to grow from 12.5 Billion USD in 2024 to 25.0 Billion USD by 2032, at a CAGR of 7%.